WCG Clinical

JUNE 12, 2023

Across the clinical research industry, “patient-centricity” has been a focal point for enrollment but that’s no longer enough. We need to be talking about “participant engagement,” which better reflects the integral role participants play in the entire research process. However, only 15% of patients seek care at these centers.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

WCG Clinical

JANUARY 12, 2024

Recruitment and retention may appear to be simplistic in their primary functions. Thus, an absence of process or lack of experience in one area can significantly affect others, leading to a cascade of problems that undermine recruitment and retention plans. Five Elements Impacting Recruitment and Retention 1.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

WCG Clinical

JULY 25, 2023

WCG continues to make improvements to My Patient, its web-based workflow and participant management tool. These upgrades enhance efficiency, participant pathway management, and user experience. My Patient facilitates the prescreening of potential participants from all referral sources.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Production 52

WCG Clinical

AUGUST 7, 2023

Patient enrollment goes beyond merely identifying individuals for your next trial. The goal isn’t merely to enroll patients, it’s to successfully complete the study. To that end, we’re going to identify ways sponsors and CROs can help sites optimize enrollment capacity and improve overall study enrollment and retention.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

XTalks

NOVEMBER 29, 2022

The goal of the ACS CAN is to “empower advocates across the country to make their voices heard and influence evidence-based public policy change as well as legislative and regulatory solutions that will reduce the cancer burden.”. Adams is a Senior Analyst for Policy and Legislative Support – Emerging Science at the ACS CAN.

Trials 98

Trials Clinical Trials Clinical Trials Development 98

pharmaphorum

NOVEMBER 19, 2021

Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

Cloudbyz

AUGUST 17, 2020

Here are some of the hot features that most organizations are currently looking for in their eConsent solution: User Friendly. A user friendly eConsent form provides a seamless experience for the participants. Configuring lag time allows participants to take their time in understanding the study. Authentication. Query handling.

Clinical Research 98

Clinical Research Licensing Licensing Containment 98

Cloudbyz

JUNE 10, 2020

A patient-facing study website provides patients and participants with a comprehensive list of actively recruiting studies across different therapeutic areas and disease conditions. This, in turn, directly correlates to increased patient retention and creates an environment where the patient is in the center of the clinical trial process.

Clinical Trials 110

Clinical Trials Clinical Trials Trials Clinical Research 110

Cloudbyz

MARCH 6, 2023

These operations involve multiple stakeholders, including clinical trial sponsors, contract research organizations (CROs), site personnel, and study participants. A unified digital platform can also improve patient recruitment and retention by making it easier for participants to access study information and communicate with site personnel.

Clinical Trials 52

Clinical Trials Clinical Trials Compliance Trials 52

Roots Analysis

OCTOBER 29, 2023

However, clinical trials are prone to significant delays, primarily due to various constraints, such as insufficient patient recruitment, inefficient study protocols and low patient retention. Over time, the healthcare industry needs an advanced technological solution to overcome such delays.

Clinical Trials 40

Clinical Trials Clinical Trials Clinical Research Trials 40

ACRP blog

JANUARY 10, 2024

Nadege Gunn: Need for study-agnostic funding for sites in diverse areas “The need for improved diversity of all kinds among trial participants will continue in 2024, with sponsor and CRO support critical to success,” said Nadege T. A promising approach is to recruit early-career staff from non-traditional backgrounds.

Clinical Trials 64

Clinical Trials Clinical Trials Trials Clinical Research 64

XTalks

MAY 24, 2023

Leading health solutions company CVS Health recently disclosed that its clinical trial business will shut down just two years after its initiation in May 2021. This scale was not reached in the later trials which only received around 33,000 participants.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharmacy 97

VirTrial

SEPTEMBER 5, 2023

We explored the effectiveness of electronic informed consent compared to using a paper informed consent form (ICF) in relation to patient comprehension, patient acceptability, study enrollment and retention rates, the time taken by patients to complete the consenting process, and site workload.

Trials 52

Trials Development Research 52

pharmaphorum

JANUARY 27, 2023

These challenges pertaining to burnt-out healthcare employees have resulted in major clinical trial workflow issues, including the impact of patients’ willingness to participate in trials, and their ability to enrol. This reallocation of time is a major factor among clinical research sites in improving employee retention rates.

Clinical Trials 109

Clinical Trials Clinical Trials Trials Clinical Research 109

XTalks

NOVEMBER 20, 2023

Prioritizing Patient Participation in Clinical Trials Incorporating patients in the planning, strategy and recruitment stages of a study is essential to ensure that clinical research genuinely reflects patient needs. Being attuned to and proactively addressing these challenges is pivotal for retaining participants.

Clinical Research 90

Clinical Research Research Clinical Trials Clinical Trials 90

pharmaphorum

JUNE 30, 2022

This means designing or evaluating protocols for elements that impact enrolment, including reducing patient burden, patient-site friction, and competitive trials. Our industry has a long-standing commitment to expanding trial access and participation, especially among traditionally underrepresented populations. Patient access.

Trials 63

Trials Development Drugs Clinical Trials 63

XTalks

AUGUST 4, 2022

This started back in 1993 when the FDA established guidelines to increase diversity by gender and race/ethnicity of participants in clinical trials that were contributing to new drug approvals. If you want to do a hypertension or hyperlipidemia trial where the enrollment ranges 18 to 80, age distribution by race might not matter as much.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

ACRP blog

FEBRUARY 29, 2024

About 80% of clinical trials fail to achieve enrollment targets and timelines, with resulting delays costing up to $8 million per day in lost revenues for sponsors.{1}Contributing Promising sites are ones where a physician is enthusiastic about participating in clinical research. substantial amendments.{2} substantial amendments.{2}

Clinical Research 52

Clinical Research Clinical Research Coordinator Trials Research 52

Crucial Data Soutions

NOVEMBER 9, 2021

Here at CDS, we’ve long envisioned the mobile app as an end-to-end solution, encapsulating integral functions from electronic patient-reported outcomes (ePRO) and electronic data capture (EDC) to clinical trial management system (CTMS) and randomization and trial supply management (RTSM). Improved study enrollment and retention rates.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Big Data 52

Cloudbyz

MAY 16, 2021

These solutions accommodate innumerable benefits of technology, advanced applications, electronic devices, online social engagement platforms, artificial intelligence, robotic process automation, machine learning, among others. What are the Benefits of Virtual Clinical Trial Solutions/ Decentralized Clinical Trial Solutions?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

ACRP blog

SEPTEMBER 11, 2023

Empowered by revolutionizing artificial intelligence (AI) enabled DHTs, investigators noted that DCTs could yield extraordinary results in accuracy in data acquisition, patient outreach and engagement, retention, and communication.[ iii] , [iv] , [v] Moving Beyond COVID-19: The Benefits of DCTs In May of 2023, the U.S. In the U.S.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Drugs 69

Cloudbyz

JUNE 11, 2023

Decentralized Clinical Trials (DCTs), also known as remote or virtual trials, are an innovative approach to executing clinical trials that permit remote participation, execution, and data accumulation. Participant Interaction: Traditional trials necessitate face-to-face interactions between participants and investigators.

Clinical Trials 74

Clinical Trials Clinical Trials Trials Compliance 74

WCG Clinical

JULY 17, 2023

Sponsors and provider organizations have the power to make trials more participant- and site- friendly and, at the same time, make trials more efficient. These patients were wary of clinical trials, in stark contrast to the positive experience of actual participants. Now, we’ll look at some solutions. So how do we engage them?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Cloudbyz

MARCH 17, 2021

Further, a collaborative approach promotes informed decision-making among the patients with better trust in the on-going clinical trial procedure and enthusiastic participation. A proactive methodology nurtures better patient enrollment with an increased retention rate. Regulatory bodies governing clinical trials.

Clinical Trials 71

Clinical Trials Clinical Trials Trials Clinical Research 71

XTalks

JANUARY 17, 2024

In this pursuit, the importance of real-world data (RWD) in advancing lupus solutions cannot be overstated. Read on to explore why companies should consider including RWD for their lupus solution development. What is the role of RWD in developing lupus solutions?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

Find Me Cure

APRIL 2, 2020

One of the main barriers between new treatments and the patients who need them, apart from limited awareness about clinical trials, is not enough patient participation in research. Many promising new drugs never get to the market not because they’re ineffective or unsafe but because clinical trials fail to recruit enough participants. .

Clinical Trials 79

Clinical Trials Clinical Trials Trials Research 79

Placebo Control

JULY 25, 2016

It is becoming increasing accepted within the research community that patient engagement leads to a host of positive outcomes – most importantly (at least practically speaking) improved clinical trial recruitment and retention. More importantly, it's worthy of being rigorously tested against other recruitment and retention approaches.

Trials 40

Trials Clinical Trials Clinical Trials Research 40

Cloudbyz

FEBRUARY 3, 2021

Because of their criticality, the success of clinical trials is hugely dependent on patient recruitment and retention. Despite the constraints, the sponsors and CROs found innovative ways to involve direct-to-patient approaches for patient recruitment and retention in the clinical trials. Wrapping Up.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Doctors 52

pharmaphorum

NOVEMBER 15, 2022

How could a trial be run if participants couldn’t leave their homes to get to the clinic or felt uncomfortable doing so due to the spread of the virus? These included better clinical trial outcomes (37%), better recruitment and enrolment (36%), and better patient experiences (36%).

Clinical Research 104

Clinical Research Research Clinical Trials Clinical Trials 104

WCG Clinical

JULY 17, 2023

Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report , gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

Cloudbyz

APRIL 8, 2024

This could lead to increased patient participation and retention. Patient enrollment and randomization Monitor for patient enrollment and randomization to ensure that the trial is proceeding according to the planned timeline and patient recruitment goals.

Clinical Trials 79

Clinical Trials Clinical Trials Trials Development 79

Drug Discovery World

APRIL 10, 2024

Clinical trial design and patient centricity Integrating patient centricity into trial design is one method of ensuring that it is a principal element of the trial, and that participants will be able to benefit from it. Deirdre Albertson , Vice President, Project Management, Cardiovascular/Metabolic Division, ICON, Jack L.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Hormones 52

Cloudbyz

FEBRUARY 3, 2021

Patients are invaluable for clinical trials, and hence the biggest challenge for conducting a clinical trial successfully is patient recruitment and retention. Such convenient and unobtrusive virtual trials can help reduce dropout rates and boost enrolment. Global Site Solutions Summit. Global Site Solutions Summit.

Clinical Trials 87

Clinical Trials Clinical Trials Trials Packaging 87

Cloudbyz

JUNE 13, 2023

Patient Recruitment and Retention: Patient recruitment and retention efforts are crucial for successful trials. Budgets should consider expenses related to advertising, screening, enrolling, and retaining participants. Incentives for patient participation and compensation for their time and travel may also be required.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Marketing 69

XTalks

FEBRUARY 4, 2021

The general problem of return of results to participants remains an issue for the world in general, says Dr. Sawcer. “By And this really helps us to identify and maintain relationships with our study participants, which is critical for some of these longitudinal research cohort studies.”. So they need to be engaged at every stage.”.

Research 98

Research Biobanking Drugs Genome 98

Drug Discovery World

FEBRUARY 20, 2024

Obtaining consent from patients or healthy volunteers is a fundamental requirement for enrolling participants on to clinical trials. This can be a lengthy and complex process which must ensure participants are fully informed of all aspects pertaining to the trial. due to updated safety information or addition of new analysis.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharma Companies 52

Drug Discovery World

FEBRUARY 20, 2024

Obtaining consent from patients or healthy volunteers is a fundamental requirement for enrolling participants on to clinical trials. This can be a lengthy and complex process which must ensure participants are fully informed of all aspects pertaining to the trial. due to updated safety information or addition of new analysis.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharma Companies 52